A novel antiangiogenic effect for telomerase-specific virotherapy through host immune system.
Ikeda Y, Kojima T, Kuroda S, Endo Y, Sakai R, Hioki M, Kishimoto H, Uno F, Kagawa S, Watanabe Y, Hashimoto Y, Urata Y, Tanaka N, Fujiwara T.
Ikeda Y, et al.
J Immunol. 2009 Feb 1;182(3):1763-9. doi: 10.4049/jimmunol.182.3.1763.
J Immunol. 2009.
PMID: 19155526